🇺🇸 FDA
Patent

US 6673778

Enzyme inhibitors for metabolic redirection

expired A61KA61K31/337A61K38/00

Quick answer

US patent 6673778 (Enzyme inhibitors for metabolic redirection) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/337, A61K38/00